Ultimate Gp200000: Rpb1 Ctd(1615-1621-lys)-glcnac(1619) Series [WGKYrbn2]

GP200000: RPB1 CTD Glycopeptide

Welcome to the cutting-edge GP200000: RPB1 CTD Glycopeptide, a synthetic variant of the Carboxy Terminal Domain (CTD) of the DNA-directed RNA polymerase II (Pol II) subunit RPB1. This high-quality glycopeptide is meticulously designed to offer researchers a reliable tool for studying the crucial functions of the CTD in transcriptional regulation and RNA processing. The CTD, composed of up to 52 heptapeptide repeats (YSPTSPS), is a dynamic region that undergoes extensive modifications, including phosphorylation, glycosylation, and proline isomerization, which are essential for polymerase activity.

• Highly purified: Our GP200000: RPB1 CTD Glycopeptide is rigorously purified to ensure a high level of purity, minimizing potential contaminants and providing you with a reliable research tool.
• Structural integrity: The glycopeptide maintains the natural structure of the CTD, allowing for accurate modeling and study of its biological functions.

Key Features and Specifications

The GP200000: RPB1 CTD Glycopeptide is a synthetic YSPTS*PSK-NH2 glycopeptide, where S* represents the GlcNAcβ-O-Ser modification. This specific modification is crucial for understanding the role of glycosylation in the CTD's function. The product is supplied as a lyophilized powder, making it easy to reconstitute and use in various experimental settings.

• Applications: The GP200000: RPB1 CTD Glycopeptide is ideal for in vitro studies, including binding assays, protein-protein interactions, and structural analysis.
• Quality assurance: Each batch of the glycopeptide is accompanied by a certificate of analysis, guaranteeing its identity, purity, and concentration.

Practical Uses and Benefits

Utilizing the GP200000: RPB1 CTD Glycopeptide in your research can provide a deeper understanding of the molecular mechanisms underlying transcriptional regulation and RNA processing. Its synthetic nature ensures consistent results across experiments, making it a valuable resource for academic and industrial researchers.

• Enhanced research outcomes: The GP200000: RPB1 CTD Glycopeptide facilitates the exploration of CTD modifications and their impact on polymerase activity, leading to significant advancements in the field.
• Cost-effective: By offering a high-quality, cost-effective solution, the GP200000: RPB1 CTD Glycopeptide helps streamline your research budget without compromising on performance.